Inter-observer variability in needle reconstruction can substantially affect dosimetry for individual patients. Especially marker-based CBCT-TRUS registrations can help to ensure accurate reconstructions for improved treatment planning.
Keyphrases
- end stage renal disease
- radiation therapy
- image quality
- prostate cancer
- ultrasound guided
- chronic kidney disease
- newly diagnosed
- ejection fraction
- high dose
- peritoneal dialysis
- prognostic factors
- cone beam computed tomography
- computed tomography
- squamous cell carcinoma
- high resolution
- patient reported outcomes
- magnetic resonance
- low dose
- monte carlo
- dual energy